<DOC>
	<DOCNO>NCT00223496</DOCNO>
	<brief_summary>1 . Determine change symptomatology function refractory bipolar depression , treat combination DEP+AZP period 12 week 2 . Determine tolerability safety AZP add DEP treatment refractory bipolar depression</brief_summary>
	<brief_title>12- Week Open Label Treatment Refractory Bipolar Depression</brief_title>
	<detailed_description>) Determine change symptomatology function refractory bipolar depression , treat combination DEP+AZP period 12 week 2 ) Determine tolerability safety AZP add DEP treatment refractory bipolar depression</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<criteria>diagnosis bipolar disorder I II accord M.I.N.I . patient sign informed consent male , female use effective birth control child bear age age 18 currently depressed phase , without psychotic feature , illness base DSMIV/MINI criterion score 19 MADRS history treatment refractory bipolar depression define failure depressive episode respond mood stabilizer alone combination 2 mood stabilizer combination mood stabilizer antidepressant current liver disease , illness precluding use depakote er patient treat DEP AZP combination past Alcohol/drug dependence past one month CNS neoplasms , demyelinate disease , degenerative neurological condition active CNS infection history seizure , know EEG frank paroxysmal activity , know CT brain show gross structural abnormality , cerebral vascular disease history structural brain damage trauma thyroid dysfunction unstable general medical condition require antipsychotic abilify</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Bipolar Depression</keyword>
	<keyword>Refractory</keyword>
</DOC>